These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10188722)

  • 1. Genetic pattern of prostate cancer progression.
    Saric T; Brkanac Z; Troyer DA; Padalecki SS; Sarosdy M; Williams K; Abadesco L; Leach RJ; O'Connell P
    Int J Cancer; 1999 Apr; 81(2):219-24. PubMed ID: 10188722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.
    Nishizuka S; Tamura G; Terashima M; Satodate R
    J Pathol; 1998 May; 185(1):38-43. PubMed ID: 9713358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic heterogeneity of surgically resected prostate carcinomas and their biopsy specimens is related to their histologic differentiation.
    Takimoto Y; Shimazui T; Akaza H; Sato N; Noguchi M
    Cancer; 2001 Jan; 91(2):362-70. PubMed ID: 11180083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.
    von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
    Clin Cancer Res; 2004 Feb; 10(3):1064-73. PubMed ID: 14871986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.
    Padalecki SS; Troyer DA; Hansen MF; Saric T; Schneider BG; O'Connell P; Leach RJ
    Int J Cancer; 2000 Mar; 85(5):654-8. PubMed ID: 10699945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
    Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
    Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
    Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
    Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma.
    Konishi N; Nakamura M; Kishi M; Ishida E; Shimada K; Matsuyoshi S; Nagai H; Emi M
    Cancer Sci; 2003 Sep; 94(9):764-8. PubMed ID: 12967473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
    Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
    Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
    Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
    Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.
    Wooten EC; Fults D; Duggirala R; Williams K; Kyritsis AP; Bondy ML; Levin VA; O'Connell P
    Neuro Oncol; 1999 Jul; 1(3):169-76. PubMed ID: 11550311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.
    Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P
    Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genetic markers for prostatic cancer progression.
    Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
    Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
    Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
    Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas.
    Pinto AP; Lin MC; Mutter GL; Sun D; Villa LL; Crum CP
    Am J Pathol; 1999 Apr; 154(4):1009-15. PubMed ID: 10233839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.